ClinicalTrials.Veeva

Menu

Investigation of Blood Glucose and Insulin Response After Intake of Vitalose

B

Beneo

Status

Completed

Conditions

Healthy Adults

Treatments

Dietary Supplement: sucrose
Dietary Supplement: isomaltulose
Dietary Supplement: glucose
Dietary Supplement: Vitalose

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04596709
BTS1586/20

Details and patient eligibility

About

The aim of this study is to assess the postprandial glucose and insulin response of Vitalose.

Enrollment

13 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy adults
  • Age 18-50 years
  • BMI ≥18.5 and ≤30.0 kg/m²

Exclusion criteria

  • acute or chronic disease
  • food allergy or intolerance
  • intake of medications which affect glucose tolerance

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

13 participants in 4 patient groups, including a placebo group

Vitalose
Active Comparator group
Description:
dissolved in water
Treatment:
Dietary Supplement: Vitalose
isomaltulose
Active Comparator group
Description:
dissolved in water
Treatment:
Dietary Supplement: isomaltulose
sucrose
Placebo Comparator group
Description:
dissolved in water
Treatment:
Dietary Supplement: sucrose
glucose
Placebo Comparator group
Description:
dissolved in water
Treatment:
Dietary Supplement: glucose

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems